St. Johns Investment Management Company LLC Has $1.42 Million Stock Position in CVS Health Co. (NYSE:CVS)

St. Johns Investment Management Company LLC grew its position in shares of CVS Health Co. (NYSE:CVS) by 37.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,799 shares of the pharmacy operator’s stock after acquiring an additional 4,878 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $1,420,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CVS. Atticus Wealth Management LLC raised its stake in shares of CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. USA Financial Formulas grew its holdings in CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new position in CVS Health in the 4th quarter valued at $32,000. Creekmur Asset Management LLC acquired a new stake in shares of CVS Health during the 4th quarter worth $34,000. Finally, Steph & Co. grew its holdings in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Barclays reduced their target price on CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, May 2nd. Cantor Fitzgerald reiterated a “neutral” rating and issued a $58.00 target price on shares of CVS Health in a research report on Wednesday, June 12th. SVB Leerink restated a “market perform” rating and set a $60.00 price objective (down from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Leerink Partnrs downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Finally, Truist Financial reiterated a “buy” rating and issued a $66.00 target price (down from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. Eleven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Stock Performance

Shares of CVS Health stock opened at $60.63 on Thursday. The business’s fifty day simple moving average is $60.16 and its 200 day simple moving average is $70.45. The firm has a market capitalization of $76.11 billion, a P/E ratio of 10.65, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business’s revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.20 earnings per share. As a group, analysts anticipate that CVS Health Co. will post 7.02 EPS for the current year.

Insider Buying and Selling at CVS Health

In other news, Director Edward J. Ludwig bought 1,000 shares of the stock in a transaction on Thursday, May 2nd. The shares were purchased at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.